AI-generated summary
The authors pooled seven randomized controlled trials with 660 patients to assess platelet-rich plasma (PRP), alone or with low intensity shock wave therapy, for erectile dysfunction. They report that PRP was associated with better erectile function scores at 12 and 24 weeks, but not at 4 weeks, and the authors state that larger clinical trials are needed to verify these findings.
- Participants
- 660
- Studies included
- 7
- Who or what was studied
- Patients with erectile dysfunction
- Limits stated in the abstract
- The authors state that the findings still require large-scale clinical trials for verification.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Meta-analysis, Systematic review, Control group, Minimal clinically important difference. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.